| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 1, 2019Virtual Press Office and PR Newswire: General Trade show news
Market doldrums got you down? Air cargo global slump making you depressed? Cancelling some cargo flights or watching only partial loads taking off with reduced yields? Well, just like the old rock...
-
Jun 1, 2019Virtual Press Office and PR Newswire: General Trade show news
The results of PharmaMar's (MSE: PHM) Phase II study with lurbinectedin as a single agent for the treatment of relapsed small cell lung cancer were presented today to the American Society of...
-
Jun 1, 2019Virtual Press Office and PR Newswire: General Trade show news
Nektar Therapeutics (Nasdaq: NKTR) announced today that biomarker and clinical data from PIVOT-02 is being presented at the 2019 American Society of Clinical Oncology (ASCO) Meeting in Chicago,...
-
Jun 1, 2019Virtual Press Office and PR Newswire: General Trade show news
MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing potential new therapies for cancer, today announced data presented at ASCO 2019 from an...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
Public health nutrition professionals at Vitamin Angels, 1,000 Days, Sight & Life and Children's Investment Fund (CIFF) will address the global problem of maternal undernutrition and the case for...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
Tenneco Inc. (NYSE: TEN) will participate in the Deutsche Bank 10th Annual Global Industrials & Materials Summit to be held in Chicago, Illinois on Thursday, June 6, 2019. The webcasted...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today findings from the investigational Phase 3 TITAN study, which showed the addition of ERLEADA® (apalutamide) to androgen...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
Veloxis Pharmaceuticals (OMX: VELO) announced today that the Company's product, Envarsus XR (tacrolimus extended-release tablets), will be the subject of two oral and fifteen poster presentations...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
Paylogix®, a Third-Party Administrator for insurance payment processes paid it forward by supporting two non-profit organizations through facilitating a business attire donation drive at the...
-
May 31, 2019Virtual Press Office and PR Newswire: General Trade show news
In the months since the EU's General Data Protection Regulation (GDPR) was first enacted, the threat of fines, data breaches, and loss of customer trust looms large for chief marketing officers....
